Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Sleep Aids Market: By Product Type, By Application, By Distribution Channel, and Geography
Sleep Aids Market: By Product Type, By Application, By Distribution Channel, and Geography
Sleep Aids Market size was valued at US$ 62,815.10 million in 2023 and is poised to grow at a CAGR of 6.8% from 2024 to 2030. The market includes medical devices and drugs that enable induce sleep in patients with various sleep-related disorders. Sleeping aids help in the diagnosis and treatment of sleep disorders. Sleeping disorders affect the ability of individuals to sleep. Most people undergo sleeping issues owing to stress and hectic schedules. Proper sleep is one with no interruptions, which allows the body to experience a natural sleep cycle.
Sleep could be affected by various factors such as time taken to fall asleep, alcohol consumption before sleep, and duration of sleep. While some are caused by hereditary factors. Sleeping disorder leads to several chronic diseases such as diabetes, obesity, and cardiovascular diseases. Sleep is a biological necessity that regulates immunological function, modulates memory and other cognitive functions, and maintains metabolic balance. Drugs and medical equipment used to diagnose and treat sleep problems such as sleep apnea and insomnia are known as sleep aids. Sleep disorders are characterized by a lack of quality sleep, which can be caused by medical issues, physical disruptions, environmental issues, or psychiatric illnesses. These sleep problems are likely to have a negative impact on human health and contribute to a variety of chronic diseases, including hypertension, diabetes, arthritis, and stroke. As a result, it is critical to treat and diagnose these problems as soon as possible.
Study Period
2024-2030Base Year
2023CAGR
6.80%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Burgeoning the prevalence of sleep disorders is expected to drive the growth of sleep aids market. According to Centers for Disease Control and Prevention (CDC), around 49.2 million people with sleeping disorder in the year 2017. The increasing use of the caffeine, tobacco and alcoholic products is expected to enhance the growth of sleep aids market. The stressful lifestyle, high work pressures is expected to fuel the growth of market. However, the side effects associated with the intake of the sleeping pills on regular basis is anticipated to hamper the growth of sleeping aids market. The patent expiration of several drugs related with sleeping disorder is dampen the growth of sleep aids market.
Geographically, global sleep aids market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americasleep aids market is anticipated to expand at unprecedented growth rates due to increase in the prevalence of sleeping disorders, followed by Europe and Asia Pacific. According to the American Academy of Sleep Medicine, approximately 25 million people experienced sleep apnea disorder in the U.S. in 2014. The Asia Pacific sleep aids market is expected to grow at significant CAGR in forecasted period. As per Food and Drug Administration (FDA), around 339 million sleeping pills that were sold in the Japan.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 62,815.10 million |
|
Market CAGR |
6.80% |
|
By Product Type |
|
|
By Application |
|
|
By Distribution Channel |
|
Download Free Sample Report
The global sleep aids market size was valued at US$ 62,815.10 million in 2023 and is projected to grow at a CAGR of 6.8% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The sleep aids market key players are Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), Care Fusion Corporation (U.S), Natus Medical Incorporated (U.S), Compumedics Limited. (Australia)
| 1. Executive Summary |
| 2. Global Sleep Aids Market Introduction |
| 2.1. Global Sleep Aids Market - Taxonomy |
| 2.2. Global Sleep Aids Market - Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Application |
| 2.2.3. By Distribution Channel |
| 2.2.4. By Region |
| 3. Global Sleep Aids Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Key Developments |
| 4. Global Sleep Aids Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 4.1. Medication |
| 4.1.1. Herbal Drugs |
| 4.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.1.3. Market Opportunity Analysis |
| 4.1.2. Prescription-based Drugs |
| 4.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.2.3. Market Opportunity Analysis |
| 4.1.3. Over-the-counter Drugs |
| 4.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.3.3. Market Opportunity Analysis |
| 4.2. Sleep Apnea Devices |
| 4.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3. Market Opportunity Analysis |
| 4.3. Mattresses and Pillows |
| 4.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.3.3. Market Opportunity Analysis |
| 4.4. Others |
| 4.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.4.3. Market Opportunity Analysis |
| 5. Global Sleep Aids Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Insomnia |
| 5 1 1 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Narcolepsy |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Restless Legs Syndrome |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Sleep Apnea |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Sleep Walking |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Sleep Aids Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospital Pharmacies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Online Pharmacies |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Sleep Aids Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. MEA |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Sleep Aids Market - Opportunity Analysis Index, By Application, Product Type, Distribution Channel, , , , , and Region, 2024 - 2030 |
| 8. North America Sleep Aids Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Medication |
| 8.1.1.1. Herbal Drugs |
| 8.1.1.2. Prescription-based Drugs |
| 8.1.1.3. Over-the-counter Drugs |
| 8.1.2. Sleep Apnea Devices |
| 8.1.3. Mattresses and Pillows |
| 8.1.4. Others |
| 8.2. Application Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Insomnia |
| 8.2.2. Narcolepsy |
| 8.2.3. Restless Legs Syndrome |
| 8.2.4. Sleep Apnea |
| 8.2.5. Sleep Walking |
| 8.2.6. Others |
| 8.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1. Hospital Pharmacies |
| 8.3.2. Online Pharmacies |
| 8.3.3. Others |
| 8.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.4.1. USA |
| 8.4.2. Canada |
| 9. Europe Sleep Aids Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Medication |
| 9.1.1.1. Herbal Drugs |
| 9.1.1.2. Prescription-based Drugs |
| 9.1.1.3. Over-the-counter Drugs |
| 9.1.2. Sleep Apnea Devices |
| 9.1.3. Mattresses and Pillows |
| 9.1.4. Others |
| 9.2. Application Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Insomnia |
| 9.2.2. Narcolepsy |
| 9.2.3. Restless Legs Syndrome |
| 9.2.4. Sleep Apnea |
| 9.2.5. Sleep Walking |
| 9.2.6. Others |
| 9.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Hospital Pharmacies |
| 9.3.2. Online Pharmacies |
| 9.3.3. Others |
| 9.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Germany |
| 9.4.2. France |
| 9.4.3. Italy |
| 9.4.4. Spain |
| 9.4.5. UK |
| 9.4.6. Rest of Europe |
| 10. Asia Pacific Sleep Aids Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Medication |
| 10.1.1.1. Herbal Drugs |
| 10.1.1.2. Prescription-based Drugs |
| 10.1.1.3. Over-the-counter Drugs |
| 10.1.2. Sleep Apnea Devices |
| 10.1.3. Mattresses and Pillows |
| 10.1.4. Others |
| 10.2. Application Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Insomnia |
| 10.2.2. Narcolepsy |
| 10.2.3. Restless Legs Syndrome |
| 10.2.4. Sleep Apnea |
| 10.2.5. Sleep Walking |
| 10.2.6. Others |
| 10.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Hospital Pharmacies |
| 10.3.2. Online Pharmacies |
| 10.3.3. Others |
| 10.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. China |
| 10.4.2. Japan |
| 10.4.3. South Korea |
| 10.4.4. India |
| 10.4.5. Rest of APAC |
| 11. Latin America Sleep Aids Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Medication |
| 11.1.1.1. Herbal Drugs |
| 11.1.1.2. Prescription-based Drugs |
| 11.1.1.3. Over-the-counter Drugs |
| 11.1.2. Sleep Apnea Devices |
| 11.1.3. Mattresses and Pillows |
| 11.1.4. Others |
| 11.2. Application Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Insomnia |
| 11.2.2. Narcolepsy |
| 11.2.3. Restless Legs Syndrome |
| 11.2.4. Sleep Apnea |
| 11.2.5. Sleep Walking |
| 11.2.6. Others |
| 11.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Hospital Pharmacies |
| 11.3.2. Online Pharmacies |
| 11.3.3. Others |
| 11.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Brazil |
| 11.4.2. Mexico |
| 11.4.3. Argentina |
| 11.4.4. Rest of Latin America |
| 12. MEA Sleep Aids Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Medication |
| 12.1.1.1. Herbal Drugs |
| 12.1.1.2. Prescription-based Drugs |
| 12.1.1.3. Over-the-counter Drugs |
| 12.1.2. Sleep Apnea Devices |
| 12.1.3. Mattresses and Pillows |
| 12.1.4. Others |
| 12.2. Application Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Insomnia |
| 12.2.2. Narcolepsy |
| 12.2.3. Restless Legs Syndrome |
| 12.2.4. Sleep Apnea |
| 12.2.5. Sleep Walking |
| 12.2.6. Others |
| 12.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Hospital Pharmacies |
| 12.3.2. Online Pharmacies |
| 12.3.3. Others |
| 12.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Merck & Co. (U.S) |
| 13.2.2. Cadwell (U.S) |
| 13.2.3. Teva Pharmaceutical Industries Ltd (Israel) |
| 13.2.4. Sanofi (France) |
| 13.2.5. Takeda Pharmaceutical Company Limited (Japan) |
| 13.2.6. Care Fusion Corporation (U.S) |
| 13.2.7. Natus Medical Incorporated (U.S) |
| 13.2.8. Compumedics Limited. (Australia) |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.